Albumin-mediated “Unlocking” of supramolecular prodrug-like nanozymes toward selective imaging-guided phototherapy

Jingjing Han, Haidong Li, Luyang Zhao, Gyoungmi Kim, Yahui Chen, Xuehai Yan, Juyoung Yoon

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Construction of an activatable photosensitizer and integration into an adaptive nanozyme during phototherapy without producing off-target toxicity remains a challenge. Herein, we have fabricated a prodrug-like supramolecular nanozyme based on a metallic-curcumin and cyanine co-assembly. The albumin-mediated phenol AOH group transformation of nanozyme changes its adjustable oxygen stress from negative superoxide dismutase-like activity of ROS-scavenging to positive photo oxidase activity with an ROS-amplifying capacity. It further increases the depth penetration of a nanozyme in a tumor spheroid, selectively targeting tumorous phototherapy. It also triggers a signal in targeted tumor cells and helps increase cancer cell ablation. This work suggests new options for development of activatable supramolecular nanozymes and provides a synergetic prodrug-like nanozyme strategy for early diagnosis and preclinical phototherapeutics.

Original languageEnglish
Pages (from-to)7814-7820
Number of pages7
JournalChemical Science
Issue number26
StatePublished - 6 Jun 2022


Dive into the research topics of 'Albumin-mediated “Unlocking” of supramolecular prodrug-like nanozymes toward selective imaging-guided phototherapy'. Together they form a unique fingerprint.

Cite this